HHS Scores Early Win In Boehringer's Medicare Pricing Suit
Government Contracts
JULY 3, 2024
Department of Health and Human Services in Boehringer Ingelheim's challenge to a new Medicare drug price negotiation program, rejecting the pharmaceutical company's claim that the program is unconstitutional. A Connecticut federal judge on Wednesday sided with the U.S.
Let's personalize your content